Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 2, 2007, Pages 123.e1-123.e7

  Cooper, Brian C ^a   Burger, Natalie Z ^a   Toth, Michael J ^a   Cushman, Mary ^a   Sites, Cynthia K ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

c reactive protein; hormone replacement therapy; insulin sensitivity; interleukin 6; leptin

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; PLACEBO;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 33846922837     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.08.042     Document Type: Article

References (62)

1. Wu S.I., Chou P., and Tsai S.T. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54 (2001) 117-120
2. DeNino W.F., Tchernof A., Dionne I.J., et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24 (2001) 925-932
3. Rewers M., Zaccaro D., D'Agnostino R., et al., Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27 (2004) 781-787
4. Toth M.J., Tchernof A., Sites C.K., et al. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obesity 24 (2000) 226-231
5. Ley C.J., Less B., and Stevenson J.C. Sex- and menopause-associated changes in body fat distribution. Am J Clin Nutr 5 (1992) 950-954
6. Svendsen O.L., Hassager C., and Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy x-ray absorptiometry. Metabolism 44 (1995) 369-373
7. Sites C.K., L'Hommedieu G.D., Toth M.J., et al. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 90 (2005) 2701-2707
8. Goodrow G.J., L'Hommedieu G.D., Gannon B., et al. Predictors of worsening insulin sensitivity in postmenopausal women. Am J Obstet Gynecol 194 (2006) 355-361
9. Kimmerle R., Heinemann L., Heise T., et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 6 (1999) 36-42
10. O'Sullivan A.J., and Ho K.K.Y. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80 (1995) 1783-1788
11. Cagnacci A., Soldani R., Carriero P.L., et al. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74 (1992) 1396-1400
12. Duncan A.C., Lyall H., Roberts R.N., et al. The effect of estragiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 84 (1999) 2402-2407
13. Cucinelli F., Paparella P., Soranna L., et al. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140 (1999) 215-223
14. Mattiasson I., Rendell M., Tornquist C., et al. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women. Horm Metab Res 34 (2002) 583-588
15. Walker R.J., Lewis-Barned N.J., Sutherland W.H., et al. The effects of sequential combined oral 17 beta-estradiol and norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause 8 (2001) 27-32
16. Ridker P.M., Hennekens C.H., Bruing J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
17. Sites C.K., Toth M.J., Cushman M., et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 77 (2002) 128-135
18. Pradhan A.D., Mason J.E., Rossouw J.E., et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. JAMA 288 (2002) 980-987
19. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot defference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998) 847-850
20. Ridker P.M., Hennekens C.H., Rifai N., et al. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100 (1999) 713-716
21. Cushman M., Legault C., Barrett-Connor E., et al. Effects of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 100 (1999) 717-722
22. Cushman M., Meilahn E.N., Psaty B.M., et al. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 19 (1999) 893-899
23. Armellini F., Zamboni M., and Bosello O. Hormones and body composition in human clinical studies. Int J Obes Relat Metab Disord 24 (2000) S18-S21
24. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
25. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
26. Segal K.R., Landt M., and Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45 (1996) 988-991
27. Konukoglu D., Serin O., and Ercan M. Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy. Maturitas 36 (2000) 203-207
28. Elbers J.M., de Roo G.W., Popp-Snijders C., et al. Effects of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol 51 (1999) 449-454
29. Lavoie H.B., Taylor A.E., Sharpless J.L., et al. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol 51 (1999) 415-422
30. Hadji P., Gorke K., Hars O., et al. The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women. Maturitas 37 (2000) 105-111
31. Salbach B., Mawroth P.P., Kubler W., et al. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. Eur J Med Res 5 (2000) 63-66
32. Laivuori H., Koinstinen H.A., Karonen S.L., et al. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Hum Reprod 16 (2001) 1632-1635
33. Kanda T., Ichikawa S., Sumino H., et al. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy. Res Com Mol Pathol Pharmacol 107 (2000) 179-185
34. Gower B.A., Nagy T.R., Goran M.I., et al. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 85 (2000) 1770-1775
35. Cento R.M., Proto C., Spada R.S., et al. Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 52 (1999) 269-273
36. Lambrinoudaki I.V., Chrisodoulakos G.E., Panoulis C.P., et al. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women. Maturitas 48 (2004) 107-113
37. Brooks-Asplund E.M., Tupper C.E., Daun J.M., et al. Determinants of plasma leptin concentration in postmenopausal women. Mech Ageing Dev 125 (2004) 117-119
38. Castracane V.D., Kraemer R.R., Franken M.A., et al. Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil Steril 70 (1998) 472-477
39. Haffner S.M., Mykkanen L., and Stern M.P. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemol 146 (1997) 581-585
40. Kohrt W.M., Landt M., and Birge Jr. S.J. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. J Clin Endocrinol Metab 81 (1996) 3980-3985
41. Di Carlo C., Tommaselli G.A., Sammartino A., et al. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 11 (2004) 466-473
42. Tommaselli G.A., Di Carlo C., Nasti A., et al. Effects of bilateral ovariectomy and postoperative hormonal replacement therapy with 17beta-estradiol or raloxifene on serum leptin levels. Menopause 10 (2003) 160-164
43. Li W.L., Guo X.Y., Zhang J.Y., et al. Serum leptin levels of menopausal women before and after hormone replacement therapy. Di Yi Junyi Daxue Xuebao 22 (2002) 635-636
44. Di Carlo C., Tommaselli G.A., Pisano G., et al. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 7 (2000) 36-41
45. Sumino H., Takahashi T., Itoh T., et al. Plasma adiponectin levels in post-menopausal women receiving hormone replacement therapy. J Int Med Res 32 (2004) 639-645
46. Sieminska L., Wojciechowska C., Niedzoilka D., et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 54 (2005) 1610-1614
47. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
48. Sites C.K., Calles-Escandon J., Brochu M., et al. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 73 (2000) 61-65
49. Toth M.J., Sites C.K., Eltabbakh G.H., et al. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care 23 (2000) 801-806
50. Toth M.J., Sites C.K., Cefalu W.T., et al. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab 281 (2001) E113-E121
51. Macy E., Hayes T., and Tracy R. Variability in the measurement of C-reactive protein in healthy subjects: implication for reference interval and epidemiologic applications. Clin Chem 43 (1997) 52-58
52. Basiotis P.P., Welsh S.O., Cronin F.J., et al. Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence. J Nutr 117 (1987) 1638-1641
53. Thompson F.E., and Byers T. Dietary assessment resource manual. J Nutr 124 (1994) 2245S-2317S
54. Taylor B.L., Jacobs D.R., and Schucker B. A questionnaire for the assessment of leisure time physical activity. J Chronic Dis 31 (1978) 741-755
55. Kumagai S., Hommang A., and Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149 (1993) 91-97
56. Beckett T., Tchernof A., and Toth M.J. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 51 (2002) 1397-1401
57. Lacut K., Oger E., Le Gal G., et al., SARAH Investigators. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost 90 (2003) 124-131
58. Pradham AD Manson J.E., Rossouw J.E., et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. JAMA 288 (2002) 980-987
59. Frolich M., Muhlberger N., Hanke H., et al. Markers of inflammation in women on different hormone replacement therapies. Ann Med 35 (2003) 353-356
60. Pradham A.D., Cook N.R., Cook N.R., et al. C-reactive protein is independently association with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 23 (2003) 650-655
61. Margolis K.L., Bonds D.E., Rodabough R.J., et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
62. Kanaya A.M., Herrington D., Vittinghoff E., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 138 (2003) 1-9